亚洲国产一-亚洲国产系列一区二区三区-亚洲国产系列久久精品99人人-亚洲国产午夜精品乱码-国产在线精品99一卡2卡-国产在线黄色

1,3-二甲基金剛烷

 
 
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2019-06-28 09:55
 

武漢楷倫化學新材料有限公司市場

企業會員第7年
資料未認證
保證金未繳納
詳細說明
 1,3-二甲基金剛烷
英文名稱:   1,3-Dimethyladamantane
英文同義詞: Dimethyladamantane;1,3-Dimethyladamanta;1,5-Dimethyladamantane;Memantine intermediate;1,3-DIMETHYLADAMANTANE;1,3-DIMETHYL ADAMANTINE;1,3-diMethyl adaMantanone;1,3-diMethyl alkyl fund just;1,3-DIMETHYLADAMANTANE, 99+%;MeMantine Related *pound A
中文名稱:   1,3-二甲基金剛烷
中文同義詞: 美金剛雜質A;1,3-二甲基金剛烷;1,3-二甲基金剛烷,98%
CBNumber:   CB4335302
分子式: C12H20
分子量: 164.29
CAS號:702-79-4
MOL File:   702-79-4.mol化學性質
熔點 :  -30 °C
沸點 :  201.5 °C
密度 :  0.886 g/mL at 25 °C(lit.)
折射率 :    n20/D 1.478(lit.)
閃點 :  127 °F
穩定性: Stable. In*patible with strong oxidizing agents. Flammable.
CAS 數據庫: 702-79-4(CAS Database Reference)
NIST化學物質信息:   Adamantane, 1,3-dimethyl-(702-79-4)
化學性質:無色液體,密度0.886。
用途:美金剛中間體。
用途:主要用于醫藥的合成等,制造***美金剛等,治療療阿爾茨海默型老年癡呆癥
用途:1,3-二甲基金剛烷主要用于醫藥的合成等,制造***美金剛等,治療阿爾茨海默型老年癡呆癥。
用途:用作藥物美金剛的中間體
 
舉報收藏 0評論 0
更多>本企業其它產品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |